SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

___________

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): December 21, 2016 (December 16, 2016)

 

PARETEUM CORPORATION

(Exact name of registrant as specified in Charter)

 

 

Delaware 000-030061 95-4557538
(State or other jurisdiction of
incorporation)
(Commission File Number) (IRS Employer
Identification No.)

  

 

100 Park Avenue, New York City, New York 10017, United States of America

(Address of Principal Executive Offices) (Zip Code)

 

Registrant's telephone number, including area code: (212) 984-1096

 

N/A

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

1  

 

 

Item 1.01 Entry into a Material Definitive Agreement.

 

On December 16, 2016, Pareteum Corporation (the “Company”) entered into a letter agreement (the “Agreement”) with certain holders (the “Holders”) of 9% Unsecured Subordinated Convertible Promissory Notes in the aggregate amount of $3,548,000 (the “Notes”) and warrants (“Warrants”) previously issued by the Company pursuant to a private placement memorandum dated December 1, 2015, as amended.

 

Pursuant to the Agreement, the Company and the Holders agreed to modify certain terms of the Notes whereby the principal amount thereof will be increased by ten percent (10%), which interest shall begin to accrue as of the date of the Agreement. In addition, the holders of the Notes are granted the right, exercisable at any time prior to the maturity date of the Note, to convert the principal amount then outstanding into shares of the Company’s common stock, at a conversion price of fifteen cents ($0.15) per share. Upon a voluntary conversion prior to the maturity date, 100% of the interest that would have been payable between the date of the voluntary conversion and the maturity date (the “Unpaid Interest Amount”) shall be converted into such number of shares of Common Stock equal to the Unpaid Interest Amount divided by the conversion price. Further, the parties have agreed to the removal of certain anti-dilution protections granted under the Note.

 

The Agreement also provides for a ten percent (10%) increase in the number of shares of common stock issuable upon the exercise of the Warrants, as well as a reduction in the exercise price for the Warrants to fifteen cents ($0.15) per share. Further, certain provisions contained in the Warrants granting the Holders full ratchet anti dilution protection have also been deleted pursuant to the Agreement.

 

The Holders were further granted certain piggy back registration rights under the Agreement.

  

The foregoing description of the Agreement does not purport to be complete and is qualified in its entirety by reference to the Agreement, a copy of which is filed as Exhibit 10.1 to this Current Report on Form 8-K.

 

Item 3.02 Unregistered Sales of Equity Securities.

 

The information set forth in Item 1.01 of this Current Report on Form 8-K concerning the Agreement is incorporated herein by reference.

 

As of December 16, 2016, Holders of an aggregate of $1,150,000 of Notes have provided the Company with a conversion notice. The issuance of the shares of the Company’s common stock under the Agreement is pursuant to an exemption from registration under Section 4(a)(2) and Regulation D of the Securities Act.

 

Item 8.01 Other Events

 

The Company previously disclosed a December 31, 2016 plan deadline date under NYSE MKT rules, and remains in discussions with the Exchange regarding a further potential extension of time, pursuant to NYSE MKT rules.

 

2  

 

 

Item 9.01 Financial Statements and Exhibits.

 

Set forth below is a list of Exhibits included as part of this Current Report.

 

10.1       Letter Agreement

 

3  

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

 

       

 Dated: December 21, 2016

 

PARETEUM CORPORATION  
       
  By:   /s/ Alexander Korff  
 

Name: Alexander Korff

 
  Title: General Counsel & Secretary  

 

4  

 

 

 

 

Exhibit 10.1

 

LETTER AGREEMENT

 

This Letter Agreement (the “ Agreement ”) is entered into by and between Pareteum Corporation, (formerly Elephant Talk Communications Corp.), a Delaware corporation (the “ Company ”) and the undersigned holder of previously issued Company securities. The purpose of this Agreement is to amend the terms of (i) that certain 9% Unsecured Subordinated Convertible Promissory Note (the “ Note ”), dated December 18, 2015, issued by the Company to the undersigned holder (the “ Holder ”) of the Note and (ii) that certain Common Stock Warrant (the “ Warrant ”) issued by the Company on December 18, 2015 to the Holder. Capitalized terms used herein but not otherwise defined shall have the meaning as set forth in the Note and Warrant.

 

WHEREAS , the Holder is entitled to a cash payment equal to ten percent (10%) of such Holder’s original investment in the Note and Warrant upon the sale of the Company’s wholly owned subsidiary, ValidSoft Limited (“ ValidSoft ”), pursuant to Supplement No. 3 dated March 24, 2016 to Confidential Private Placement Memorandum dated December 1, 2015 (“ Supplement No. 3 ”);

 

WHEREAS , the Company has recently sold ValidSoft, and the Company desires to amend the terms of Supplement No. 3 to provide for alternate consideration in lieu of the cash payment described in Supplement No. 3 (the “Amendment”); and

 

WHEREAS , the Company desires to provide the alternate consideration to such Holders who have provided to the Company, on or before December 15, 2016, their consent to the Amendment.

 

NOW THEREFORE , for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Company and Holder agree as follows:

 

1. Amendments to the Note .

 

(a)       Beginning on the date on which this Agreement is fully executed by both the Holder and the Company, the Principal amount of the Note is hereby increased by ten percent (10%) (the difference between the original Principal amount of the Note and the new Principal amount of the Note described in this Agreement, the “ Additional Principal Amount ”). Interest shall begin to accrue with respect to the Additional Principal Amount on the date of this Agreement.

 

(b)       The Conversion Price set forth in the Note shall be revised to fifteen cents ($0.15) per share of Common Stock, subject to further adjustment for the events referred to in Section 4(d) of the Note (as modified by Section 1(d) below).

 

 

(c)       Section 4(b) of the Note entitled Voluntary Conversion is amended and restated as follows:

 

“Voluntary Conversion. Each holder of the Notes shall have the right, exercisable at any time prior to the Maturity Date, to convert the principal amount then outstanding into shares of Common Stock, at the Conversion Price. In addition, upon a voluntary conversion prior to the Maturity Date, 100% of the interest that would have been payable between the date of the voluntary conversion and the Maturity Date (the “Unpaid Interest Amount”) shall be converted into such number of shares of Common Stock equal to the Unpaid Interest Amount divided by the Conversion Price (the “Unpaid Interest Shares”).”

 

 

 

 

(d)       Holder hereby agrees to the removal and deletion of the provisions in Section 4(d)(iii) and (iv) of the Note.

 

 

2.        Piggyback Registration . If at any time after the date hereof and terminating one year from the date hereof, the Company proposes to register (including for this purpose a registration effected by the Company for stockholders other than the Holders) any of its stock or other securities under the Securities Act of 1933, as amended (the “Securities Act”), in connection with the public offering of such securities (other than a registration statement on Form S-8, Form S-4 and /or registration relating solely to the sale of securities to participants in a Company stock plan, a registration relating to a corporate reorganization or other transaction under Rule 145 of the Securities Act, a registration on any form that does not include substantially the same information as would be required to be included in a registration statement covering the sale of the Registrable Securities), the Company shall, at such time, promptly give each Holder written notice of such registration. Upon the written request of each Holder given within ten (10) days after mailing of such notice by the Company, the Company, subject to applicable rules and regulations of the Securities and Exchange Commission, shall use commercially reasonable efforts to cause to be registered under the Securities Act, at its expense, all of the shares of common stock issuable upon conversion of the Notes and shares of common stock issuable upon exercise of the Warrants (the “Registrable Securities”) that each such Holder has requested to be registered. Each Holder shall furnish to the Company such information regarding the Holder and the distribution proposed by it as the Company may reasonably request in connection with any registration or offering referred to in this Section. Notwithstanding anything to the contrary, in this Section, the piggy rights granted pursuant to this Section shall cease and the Registrable Securities shall cease to be Registrable Securities upon the earliest to occur of the following: (a) the sale of any Registrable Securities pursuant to the Registration Statement or Rule 144 under the Securities Act; or (B) if the Registrable Securities become eligible for resale by its holder under Rule 144, under the Securities Act, without the requirement for the Company to be in compliance with the current public information required thereunder and without volume or manner-of-sale restrictions.

 

3.        Amendment to the Warrant .

 

(a)        The Warrant is hereby amended such that the number of shares of Common Stock issuable upon exercise of the Warrant shall be increased by ten percent (10%) and the Exercise Price is reduced to $0.15.

 

(b)        The anti-dilution protection provided under the Warrant pursuant to Section 2(c) and 2(d) thereof shall, effective on the date on which this Agreement is fully executed by both the Holder and the Company, be deleted in its entirety.

 

(c)       The provision relating to the cashless exercise of the Warrant, as provided under Section 1(e) thereof, shall be amended as follows:

 

This Warrant may be exercised, in whole or in part, at such time by means of a “cashless exercise” in which the Holder shall be entitled to receive a certificate for the number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:

 

(A) = the closing price of the Common Stock on the trading day immediately preceding the date on which Holder elects to exercise this Warrant by means of a “cashless exercise,” as set forth in the applicable Notice of Exercise;

(B) = the Exercise Price of this Warrant, as adjusted hereunder; and

 

 

 

  

(X) = the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a cashless exercise.

 

4.        Acknowledgement of Compensation to Broker-Dealer . The Holder acknowledges and agrees that pursuant to the Company’s agreement with Dawson James Securities, Inc. (“Dawson James”), the Company will issue to Dawson James such number of shares of the Company’s Common Stock equal to eight percent (8%) of the aggregate amount of Notes converted pursuant to this Agreement, at a conversion rate of fifteen cents ($0.15) per share.

 

5.        Authorization . The undersigned represents that he/she has full corporate power and authority to execute this Agreement on behalf of the Holder and that the Holder is authorized to take the action set forth herein without the consent or approval of any other third party.

 

6.        No Other Amendments. Except as specifically set forth in this Agreement, there are no other amendments to the Note or the Warrant and the Note and Warrant shall remain unmodified and in full force and effect.

 

7.        Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of New York.

 

8.        Counterparts; Signature . This Agreement may be executed in one or more counterparts. In the event that any signature is delivered by facsimile transmission or any other form of electronic delivery, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such signature page were an original thereof.

 

 

 

[Signature Page Follows]

   

 

 

 

IN WITNESS WHEREOF, the parties have executed this Agreement as of December ___, 2016.

 

 

  THE COMPANY:
  PARETEUM CORPORATION
   
  By:  
  Name: Robert H. Turner
  Title: Executive Chairman

 

  

  THE HOLDER:
     
  By:  
  Name:
  Title: